Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy.
Smyth P, Ferguson L, Burrows JF, Burden RE, Tracey SR, Herron ÚM, Kovaleva M, Williams R, Porter AJ, Longley DB, Barelle CJ, Scott CJ.
Smyth P, et al. Among authors: kovaleva m.
Front Pharmacol. 2023 Dec 5;14:1296567. doi: 10.3389/fphar.2023.1296567. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38116078
Free PMC article.